446 related articles for article (PubMed ID: 24500309)
1. Podocyte-associated gene mutation screening in a heterogeneous cohort of patients with sporadic focal segmental glomerulosclerosis.
Laurin LP; Lu M; Mottl AK; Blyth ER; Poulton CJ; Weck KE
Nephrol Dial Transplant; 2014 Nov; 29(11):2062-9. PubMed ID: 24500309
[TBL] [Abstract][Full Text] [Related]
2. Causal and putative pathogenic mutations identified in 39% of children with primary steroid-resistant nephrotic syndrome in South Africa.
Nandlal L; Winkler CA; Bhimma R; Cho S; Nelson GW; Haripershad S; Naicker T
Eur J Pediatr; 2022 Oct; 181(10):3595-3606. PubMed ID: 35920919
[TBL] [Abstract][Full Text] [Related]
3. Bigenic heterozygosity and the development of steroid-resistant focal segmental glomerulosclerosis.
Löwik M; Levtchenko E; Westra D; Groenen P; Steenbergen E; Weening J; Lilien M; Monnens L; van den Heuvel L
Nephrol Dial Transplant; 2008 Oct; 23(10):3146-51. PubMed ID: 18443213
[TBL] [Abstract][Full Text] [Related]
4. NPHS2 variation in focal and segmental glomerulosclerosis.
Tonna SJ; Needham A; Polu K; Uscinski A; Appel GB; Falk RJ; Katz A; Al-Waheeb S; Kaplan BS; Jerums G; Savige J; Harmon J; Zhang K; Curhan GC; Pollak MR
BMC Nephrol; 2008 Sep; 9():13. PubMed ID: 18823551
[TBL] [Abstract][Full Text] [Related]
5. Clinical value of NPHS2 analysis in early- and adult-onset steroid-resistant nephrotic syndrome.
Santín S; Tazón-Vega B; Silva I; Cobo MÁ; Giménez I; Ruíz P; García-Maset R; Ballarín J; Torra R; Ars E;
Clin J Am Soc Nephrol; 2011 Feb; 6(2):344-54. PubMed ID: 20947785
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of the
de Almeida R; da Silva WC; Garbin HI; Itaquy TP; Dos Santos Pereira F; Garcia CD; Keitel E; Sales Luiz Vianna F; Veronese FV
Clin Nephrol; 2020 Oct; 94(4):187-196. PubMed ID: 32691731
[TBL] [Abstract][Full Text] [Related]
7. Mutations in podocyte genes are a rare cause of primary FSGS associated with ESRD in adult patients.
Büscher AK; Konrad M; Nagel M; Witzke O; Kribben A; Hoyer PF; Weber S
Clin Nephrol; 2012 Jul; 78(1):47-53. PubMed ID: 22732337
[TBL] [Abstract][Full Text] [Related]
8. Familial focal segmental glomerulosclerosis (FSGS) in a Nigerian family and exclusion of mutations in NPHS2,WT1 and APOL1.
Anochie IC; Eke FU; Okpere AN
West Afr J Med; 2012; 31(4):273-6. PubMed ID: 23468032
[TBL] [Abstract][Full Text] [Related]
9. Recessive NPHS2 (Podocin) mutations are rare in adult-onset idiopathic focal segmental glomerulosclerosis.
He N; Zahirieh A; Mei Y; Lee B; Senthilnathan S; Wong B; Mucha B; Hildebrandt F; Cole DE; Cattran D; Pei Y
Clin J Am Soc Nephrol; 2007 Jan; 2(1):31-7. PubMed ID: 17699384
[TBL] [Abstract][Full Text] [Related]
10. Report of novel genetic variation in NPHS2 gene associated with idiopathic nephrotic syndrome in South Indian children.
Dhandapani MC; Venkatesan V; Rengaswamy NB; Gowrishankar K; Ekambaram S; Sengutavan P; Perumal V
Clin Exp Nephrol; 2017 Feb; 21(1):127-133. PubMed ID: 26820844
[TBL] [Abstract][Full Text] [Related]
11. Retrospective mutational analysis of NPHS1, NPHS2, WT1 and LAMB2 in children with steroid-resistant focal segmental glomerulosclerosis - a single-centre experience.
Bińczak-Kuleta A; Rubik J; Litwin M; Ryder M; Lewandowska K; Taryma-Leśniak O; Clark JS; Grenda R; Ciechanowicz A
Bosn J Basic Med Sci; 2014 May; 14(2):89-93. PubMed ID: 24856380
[TBL] [Abstract][Full Text] [Related]
12. NPHS2 variation in sporadic focal segmental glomerulosclerosis.
McKenzie LM; Hendrickson SL; Briggs WA; Dart RA; Korbet SM; Mokrzycki MH; Kimmel PL; Ahuja TS; Berns JS; Simon EE; Smith MC; Trachtman H; Michel DM; Schelling JR; Cho M; Zhou YC; Binns-Roemer E; Kirk GD; Kopp JB; Winkler CA
J Am Soc Nephrol; 2007 Nov; 18(11):2987-95. PubMed ID: 17942957
[TBL] [Abstract][Full Text] [Related]
13. NPHS2 gene polymorphism aggravates renal damage caused by focal segmental glomerulosclerosis with COL4A3 mutation.
Sun L; Zhang X; Wang Z
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33305316
[TBL] [Abstract][Full Text] [Related]
14. WT1 and NPHS2 gene mutation analysis and clinical management of steroid-resistant nephrotic syndrome.
Ramanathan AS; Vijayan M; Rajagopal S; Rajendiran P; Senguttuvan P
Mol Cell Biochem; 2017 Feb; 426(1-2):177-181. PubMed ID: 27885584
[TBL] [Abstract][Full Text] [Related]
15. Molecular analysis of NPHS2 and ACTN4 genes in a series of 33 Italian patients affected by adult-onset nonfamilial focal segmental glomerulosclerosis.
Aucella F; De Bonis P; Gatta G; Muscarella LA; Vigilante M; di Giorgio G; D'Errico M; Zelante L; Stallone C; Bisceglia L
Nephron Clin Pract; 2005; 99(2):c31-6. PubMed ID: 15627790
[TBL] [Abstract][Full Text] [Related]
16. NPHS2 mutations in late-onset focal segmental glomerulosclerosis: R229Q is a common disease-associated allele.
Tsukaguchi H; Sudhakar A; Le TC; Nguyen T; Yao J; Schwimmer JA; Schachter AD; Poch E; Abreu PF; Appel GB; Pereira AB; Kalluri R; Pollak MR
J Clin Invest; 2002 Dec; 110(11):1659-66. PubMed ID: 12464671
[TBL] [Abstract][Full Text] [Related]
17. Recurrence of focal segmental glomerulosclerosis after renal transplantation in patients with mutations of podocin.
Bertelli R; Ginevri F; Caridi G; Dagnino M; Sandrini S; Di Duca M; Emma F; Sanna-Cherchi S; Scolari F; Neri TM; Murer L; Massella L; Basile G; Rizzoni G; Perfumo F; Ghiggeri GM
Am J Kidney Dis; 2003 Jun; 41(6):1314-21. PubMed ID: 12776285
[TBL] [Abstract][Full Text] [Related]
18. Mutations in INF2 may be associated with renal histology other than focal segmental glomerulosclerosis.
Büscher AK; Celebi N; Hoyer PF; Klein HG; Weber S; Hoefele J
Pediatr Nephrol; 2018 Mar; 33(3):433-437. PubMed ID: 29038887
[TBL] [Abstract][Full Text] [Related]
19. Screening for NPHS2 mutations may help predict FSGS recurrence after transplantation.
Jungraithmayr TC; Hofer K; Cochat P; Chernin G; Cortina G; Fargue S; Grimm P; Knueppel T; Kowarsch A; Neuhaus T; Pagel P; Pfeiffer KP; Schäfer F; Schönermarck U; Seeman T; Toenshoff B; Weber S; Winn MP; Zschocke J; Zimmerhackl LB
J Am Soc Nephrol; 2011 Mar; 22(3):579-85. PubMed ID: 21355056
[TBL] [Abstract][Full Text] [Related]
20. NPHS2 homozygous p.R229Q variant: potential modifier instead of causal effect in focal segmental glomerulosclerosis.
Kerti A; Csohány R; Wagner L; Jávorszky E; Maka E; Tory K
Pediatr Nephrol; 2013 Oct; 28(10):2061-4. PubMed ID: 23800802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
